![]() | |
Clinical data | |
---|---|
Trade names | Luvatren (discontinued) |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.012.625![]() |
Chemical and physical data | |
Formula | C22H26FNO2 |
Molar mass | 355.453 g·mol−1 |
3D model (JSmol) | |
| |
|
Moperone (Luvatren, since discontinued) is atypical antipsychotic of thebutyrophenone class[2] which is marketed inJapan for the treatment ofschizophrenia. It is anantagonist for theD2 (Ki 0.7–1.9 nM),D3 (Ki 0.1–1 nM), and5-HT2A (Ki 52 nM) receptors. It also has a high binding affinity for thesigma receptors.[3][4]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |